| 000 | 03365 a2201045 4500 | ||
|---|---|---|---|
| 005 | 20250518042936.0 | ||
| 264 | 0 | _c20200224 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1475-2840 | ||
| 024 | 7 |
_a10.1186/s12933-019-0864-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFruchart, Jean-Charles | |
| 245 | 0 | 0 |
_aThe selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. _h[electronic resource] |
| 260 |
_bCardiovascular diabetology _c06 2019 |
||
| 300 |
_a71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzoxazoles _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aButyrates _xadverse effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aPPAR alpha _xagonists |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSantos, Raul D | |
| 700 | 1 | _aAguilar-Salinas, Carlos | |
| 700 | 1 | _aAikawa, Masanori | |
| 700 | 1 | _aAl Rasadi, Khalid | |
| 700 | 1 | _aAmarenco, Pierre | |
| 700 | 1 | _aBarter, Philip J | |
| 700 | 1 | _aCeska, Richard | |
| 700 | 1 | _aCorsini, Alberto | |
| 700 | 1 | _aDesprés, Jean-Pierre | |
| 700 | 1 | _aDuriez, Patrick | |
| 700 | 1 | _aEckel, Robert H | |
| 700 | 1 | _aEzhov, Marat V | |
| 700 | 1 | _aFarnier, Michel | |
| 700 | 1 | _aGinsberg, Henry N | |
| 700 | 1 | _aHermans, Michel P | |
| 700 | 1 | _aIshibashi, Shun | |
| 700 | 1 | _aKarpe, Fredrik | |
| 700 | 1 | _aKodama, Tatsuhiko | |
| 700 | 1 | _aKoenig, Wolfgang | |
| 700 | 1 | _aKrempf, Michel | |
| 700 | 1 | _aLim, Soo | |
| 700 | 1 | _aLorenzatti, Alberto J | |
| 700 | 1 | _aMcPherson, Ruth | |
| 700 | 1 | _aNuñez-Cortes, Jesus Millan | |
| 700 | 1 | _aNordestgaard, Børge G | |
| 700 | 1 | _aOgawa, Hisao | |
| 700 | 1 | _aPackard, Chris J | |
| 700 | 1 | _aPlutzky, Jorge | |
| 700 | 1 | _aPonte-Negretti, Carlos I | |
| 700 | 1 | _aPradhan, Aruna | |
| 700 | 1 | _aRay, Kausik K | |
| 700 | 1 | _aReiner, Željko | |
| 700 | 1 | _aRidker, Paul M | |
| 700 | 1 | _aRuscica, Massimiliano | |
| 700 | 1 | _aSadikot, Shaukat | |
| 700 | 1 | _aShimano, Hitoshi | |
| 700 | 1 | _aSritara, Piyamitr | |
| 700 | 1 | _aStock, Jane K | |
| 700 | 1 | _aSu, Ta-Chen | |
| 700 | 1 | _aSusekov, Andrey V | |
| 700 | 1 | _aTartar, André | |
| 700 | 1 | _aTaskinen, Marja-Riitta | |
| 700 | 1 | _aTenenbaum, Alexander | |
| 700 | 1 | _aTokgözoğlu, Lale S | |
| 700 | 1 | _aTomlinson, Brian | |
| 700 | 1 | _aTybjærg-Hansen, Anne | |
| 700 | 1 | _aValensi, Paul | |
| 700 | 1 | _aVrablík, Michal | |
| 700 | 1 | _aWahli, Walter | |
| 700 | 1 | _aWatts, Gerald F | |
| 700 | 1 | _aYamashita, Shizuya | |
| 700 | 1 | _aYokote, Koutaro | |
| 700 | 1 | _aZambon, Alberto | |
| 700 | 1 | _aLibby, Peter | |
| 773 | 0 |
_tCardiovascular diabetology _gvol. 18 _gno. 1 _gp. 71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12933-019-0864-7 _zAvailable from publisher's website |
| 999 |
_c29764224 _d29764224 |
||